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Intuitively one might expect that activation of GABAergic inhibitory neurons results in bradycardia. In conscious animals the
opposite eﬀect is however observed. GABAergic neurons in nucleus ambiguus hold the ability to control the activity of the
parasympathetic vagus nerve that innervates the heart. Upon GABA activation the vagus nerve will be inhibited leaving less
parasympathetic impact on the heart. The picture is however blurred in the presence of anaesthesia where both the concentration
and type of anaesthetics can result in diﬀerent eﬀects on the cardiovascular system. This paper reviews cardiovascular outcomes
of GABA activation and includes own experiments on anaesthetized animals and isolated hearts. In conclusion, the impact of
changes in GABAergic input is very diﬃcult to predict in these settings, emphasizing the need for experiments performed in
conscious animals when aiming at determining the cardiovascular eﬀects of compounds acting on GABAergic neurons.
1.Introduction
Gamma-aminobutyric acid (GABA)ergic neurons are the
major contributor to neuronal inhibition in the brain. The
activity of GABAergic interneurons has profound impact on
spike timing control, neuronal rhythms, and the activity
pattern of neuronal circuits. The correct tonus for these neu-
rons are therefore critical for a number of diﬀerent condi-
tions such as attention, perception, consciousness, working
memory, sensorimotor processing, and schizophrenia [1–3].
Activation of GABAergic neurons is also applied for myore-
laxation, anxiolytic treatment, sedation, and anaesthetics [4–
6]. In addition to CNS eﬀects GABAergic neurons also have
a signiﬁcant impact on the cardiovascular system. From this
perspectiveGABAergicneuronscanaﬀectbothelectricaland
hemodynamic parameters. CNS-controlled chronotropic
eﬀects on the heart can happen via eﬀects on nucleus
ambiguus that will subsequently aﬀect the vagal tonus and
thereby heart rate [7]. Additionally it has been suggested that
GABA could have a direct eﬀect on cardiac tissue [8]. In
addition to direct or indirect eﬀect on cardiac electrical pa-
rameters GABAergic input will also aﬀect blood vessels and
therebyparticipateinthecontrolofvasculartonusandblood
pressure, which reﬂexively has eﬀects on heart rate [9].
GABA receptors come in two diﬀerent families: Iono-
tropicGABAA receptorsandmetabotropicGABAB receptors.
A description of the G-protein-coupled GABAB receptors is
beyond the scope of the present paper.
GABAA receptors are ligand-gated ion channels with
chloride conductance. The functional channel is typically
heteropentameric in structure even though homomeric ρ1,
2, and 3 receptors have been described [10]. A number of
diﬀerent subunits exist, and the exact subunit composition
will determine the electrophysiological properties of the
channel, thereby ultimately the phenotypic output in an in
vivosituation[11].ThemajorityofGABAA receptorscontain
α, β,a n dγ subunits but δ, ε, θ,a n dρ can also be present
[12]. Ligand binding to GABAA receptor has been intensively
studied, and detailed information is available. The GABA
binding site is located at the interface between the α and
the β subunit, and a number of important amino acids in
the binding pocket have been identiﬁed [13]. The eﬀect of
positive allosteric modulators is well described for GABAA
receptors exempliﬁed by benzodiazepine. The binding site is2 Advances in Pharmacological Sciences
here located between the α-γ interface [14]. Antagonist are
considered to bind in a pocket that is partly overlapping with
the agonist site, with the diﬀerence being that antagonist can
extend further into the solvent accessible cavity [15]. Pore
blockers, in the form of picrotoxin, are also valuable exper-
imental tools for addressing the eﬀects of GABAA receptors,
albeit this toxin has no therapeutic use due to induction of
convulsions.
The present paper gives an overview of the known lit-
erature of GABAergic eﬀects on the cardiovascular system
with emphasis on the cardiac vagal neurons because of their
majorimportanceincontrollingthechronotropicstateofthe
heart. Supportive information will be given for experiments
performed on isolated hearts and anaesthetized in vivo ex-
periments under inﬂuence of diﬀerent concentrations of iso-
ﬂurane.
2. Parasympathetic Control of Heart Rate
Cardiac cells hold the ability to initiate action potentials. The
sinoatrial node has the highest automaticity, and conse-
quentlythenormalheartbeatoriginatesfromhere.Theheart
activityishoweverregulatedbytheintrinsiccardiacneurons,
by hormones and by the sympathetic and parasympathetic
branches of the autonomic nervous system [16]. The para-
sympatheticcardioinhibitoryeﬀectsareopposedbythefacil-
itatory sympathetic eﬀects. In both animals and humans the
parasympathetic tonus dominates over the sympathetic at
rest [17–19]. Cardiac preganglionic neurons whose cell bod-
ies are primarily found in the nucleus ambiguus and some
in the dorsal motor nucleus of the vagus are responsible
for this tonic control of heart rate. They are also important
for the reﬂex and respiratory regulation of heart rate seen
in response to baroreceptor activation and inspiration [20].
Via the vagal nerve, the axons from these nuclei reach the
intrinsic cardiac ganglia located in the fat pads adjacent to
the right atrium [16]. From here postganglionic neurons in-
nervate the sinoatrial node, ultimately leading to activation
of cholinergic G-protein-coupled receptors (M2) and heart
rate reduction. This happens primarily through activation
of the acetylcholine-activated K+ channel GIRK, but also
by M2 receptor-induced inhibition of the adenylyl cyclase,
which ultimately leads to reduced HCN channel opening
probability [21, 22]( Figure 1). The preganglionic cardiac
vagal neurons do not hold any intrinsic pacemaker activity
and are consequently intrinsically silent [23]. Therefore, they
mustrelyonsynapticinputmediatedbybothionotropicand
G-protein-coupled receptors for controlling their ﬁring [24–
26]. Excitatory inputs to the cardiac vagal neurons include
both glutamatergic inputs predominantly from the nucleus
tractus solitarius, and pre- and postsynaptic cholinergic
nicotine receptors that can excite the cardiac vagal neu-
rons (for review see [27]). With respect to the inhibitory
GABAergic input to the cardiac vagal preganglionic neurons,
it was found that inhibition of GABAA receptor activity by
microinjectionofbicucullineintonucleusambiguusresulted
in dose-related reduction of heart rate and that the eﬀect
was reversed by the GABAA receptor agonist muscimol [7].
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Figure 1: Model of how activation of GABAergic input to the
cardiacvagalneuronsincreasesheartrate.GABAergicneuronsfrom
the nucleus tractus solitarius inhibits the preganglionic cardiac
vagal neurons, which leads to reduced postganglionic vagal input to
theheart.Consequently,themuscarinicacetylcholinereceptor(M2)
activity is reduced. Because the Gi protein no longer inhibits the
production of cAMP by the adenylyl cyclase, HCN channel activity
is increased. In addition the G protein-coupled inwardly rectifying
potassium channel (GIRK) is no longer activated. Together this will
cause the heart rate to increase.
ThisdemonstratestheimportanceofGABAergicinputtothe
nucleus ambiguus in setting the tonic heart rate level. The
phasic inhibition of cardiac vagal neurons by activation of
GABAA receptors in the nucleus ambiguus is important for
the respiratory sinus arrhythmia where the heart rate slows
during inspiration and for the baroreﬂex where changes in
arterial pressure reﬂexively cause homeostatic changes in
heart rate [28].
Upon synaptic release of GABA multiple types of postsy-
naptic GABAergic receptors on the parasympathetic cardiac
neurons in the nucleus ambiguus are activated. In vitro
electrophysiological studies found that the phasic inhibitory
currents observed after release of GABA could be blocked
by gabazine whereas gabazine-insensitive but picrotoxin-
sensitive receptors were responsible for the tonic inhibitory
synaptic currents [30]. This phenomenon is well known in
other brain areas [31]. When the tonic currents were blocked
the membrane potential depolarized and increased the ﬁring
activity of the cardiac vagal neurons. How the tonic GABA
current is activated in the nucleus ambiguus is unknown,
but a role for the GAT-1 GABA transporter is unlikely as
inhibitionofthisdidnotaugmentthemagnitudeofthetonic
GABAergic current in the vagal neurons [30]. Other mech-
anisms such as spontaneous opening of constitutive active
GABA channels could be responsible for the tonic GABAer-
gic current. Bouairi et al. further demonstrated that appli-
cation of the benzodiazepine, ﬂunitrazepam, increased the
decay time of the phasic IPSC and augmented the tonicAdvances in Pharmacological Sciences 3
current [30]. This would decrease the input resistance of the
neuron and serve as a “sink” for any excitatory inputs [30].
These ﬁndings also provide a hint to the molecular com-
position of the cardiac vagal neuron GABAA receptor. The
positive allosteric modulation by benzodiazepines requires
the presence of a γ-subunit, with the binding site located
at the α-γ interface [14]. In the brain stem α1a n dα3
are more strongly expressed than α2, α4, α5, and α6( f o r
review see [32]). However, the molecular composition of the
GABAA receptors in the cardiac vagal neurons needs to be
determined.
The sources of GABAergic neurotransmission to the car-
diac vagal neurons in the nucleus ambiguus have been inves-
tigated. Both with respect to the tonic and phasic inhibitory
GABAergic inputs they have been suggested to in part orig-
inate from the nucleus tractus solitaries (NTS) [33]. Electri-
cal stimulation of the NTS produces a GABAergic current in
the cardiac vagal neurons that can be blocked by bicuculline
[33]. An excitatory monosynaptic glutamatergic pathway
from NTS that activates NMDA and non-NMDA postsynap-
tic receptors in cardiac vagal neurons has also been identiﬁed
[26]. By photo-uncaging glutamate in the near vicinity of
GABAergic neurons and simultaneously recording from car-
diacvagalneurons,Franketal.couldidentify andmapGAB-
Aergic neurons projecting to the cardiac vagal neurons in the
nucleus ambiguus. Using this technique they identiﬁed areas
in the nucleus tractus solitarius and in the close proximity
to the nucleus ambiguus that when stimulated by uncaging
of glutamate evoked a GABAergic inhibitory response in the
cardiac vagal neurons [34].
Thenucleustractussolitariusisimportantforintegrating
the autonomic nervous system functions and so also for
cardiovascular and respiratory regulation and reﬂexes. The
NTSreceivesaﬀerentinputfromthecranialnervesandhence
information from a variety of organs and visceral regions,
including sensory information from chemoreceptors and
arterial baroreceptors [35, 36]. These sensory information is
important for the baroreﬂex, where increase in blood pres-
sure causes aﬀerent baroreﬂex activity, that activates neurons
in the NTS and possibly via the excitatory glutamatergic
pathway evokes an increase in the cardiac vagal neuron ac-
tivity and a compensatory decrease in heart rate (for review
see [20, 37]). Respiration also inﬂuences the cardiac vagal
neuron output through reﬂex mechanisms. One of these
reﬂex mechanisms is the respiratory sinus arrhythmia, which
describesthechangesintheheartratewithrespiration.From
ECG recordings this can be observed as a shortening of the
R-R interval (increased heart rate) during inspiration and a
prolongation during expiration. This phenomenon has been
suggested to save cardiac energy by eﬀectively reducing the
number of heartbeats during expiration, providing an efﬁ-
cient ventilation/perfusion matching [38]. Respiratory sinus
arrhythmia is primarily mediated by altering the ﬁring
pattern of the cardiac vagal neurons. They are silent during
inspiration and active during expiration. This rhythm is not
achieved by changes in excitatory pathways projecting to the
cardiac vagal neurons but rather by the activation of inhib-
itory pathways during inspiration which increases the GAB-
Aergic and glycinergic input to the cardiac vagal neurons,
thereby lowering the vagal tone on the heart during inspi-
ration[20, 39]. Respiratory sinus arrhythmia which has been
observed in many diﬀerent mammals is blunted, diminished
or even reverted in anaesthetised animals depending on the
anaesthetics used [40]. This demonstrates the importance
of understanding how general anaesthetics work, especially
when investigating the parasympathetic control of heart rate
orwhennovelcompoundsareinvestigatedforcardiovascular
safety liability.
3. Effects of GeneralAnaesthetics onthe Heart
Many general anaesthetics have been found to aﬀect car-
diovascular reﬂexes by interfering with the cardioinhibitory
vagalneuronsinthenucleusambiguus.Pentobarbitalisoften
used for induction of anaesthesia and is known to cause re-
spiratory depression, blunted baroreﬂex, and increased heart
rate [41]. These eﬀects are primarily related to the pentobar-
bital induced potentiation of the spontaneous postsynaptic
inhibitory currents in the cardiac vagal neurons, whereby the
cardioinhibitory parasympathetic input to the heart is de-
creased, and heart rate is increased [42]. Similarly, propo-
fol, which is also known to potentiate GABAA currents, aug-
ments the GABAergic input to the cardiac vagal neurons by
increasing both phasic and tonic GABAA receptor currents.
This evokes an increase in heart rate [43, 44]. At suprathera-
peutic propofol concentrations inhibition of the GABAergic
neurotransmission to the nucleus ambiguus is observed with
a subsequent reduction in heart rate [44]. Isoﬂurane is
known to decrease blood pressure, evoke respiratory inhibi-
tion, and to cause variable changes in heart rate depending
on the depth of anaesthesia [45, 46]. Furthermore, studies
have demonstrated that the baroreceptor reﬂex was not de-
pressed signiﬁcantly until 2.6% isoﬂurane (2X minimum
alveolar concentration (MAC)) [47]. Other reﬂexes such as
the respiratory sinus arrhythmia are however compromised
during isoﬂurane exposure at clinically relevant concen-
trations [48]. Isoﬂurane increases heterologously expressed
GABAA receptor currents with the eﬀect peaking around
1 MAC. The concentration response curve is bell shaped,
and eventually isoﬂurane produces an inhibition of the
GABAA steady-state current as the isoﬂurane concentration
increases. In order to lower the concentration of isoﬂu-
rane needed to achieve the desired anaesthetic depth, the
volatile anaesthetic is often supplemented with nitrous oxide
(N2O). From electrophysiological recordings of heterolo-
gously expressed GABAA receptors addition of N2O results
in an augmentation of the potentiating eﬀects of isoﬂurane
[49]. The enhancement of GABAA receptor currents by
isoﬂurane results in prolonged inhibitory postsynaptic cur-
rents, increased Cl− inﬂux, and reduced excitability. In addi-
tion, recordings from cardiac vagal neurons in the nucleus
ambiguus demonstrated that isoﬂurane also enhanced the
tonic GABAergic current [43]. Taken together this augmen-
tation of the GABAergic input to the cardiac vagal neurons
would result in reduced vagal excitability. This would shift
the parasympathetic/sympathetic balance resulting in tachy-
cardia.However,Wangalsomeasuredareducedfrequencyof
GABAergic IPSC after exposure to isoﬂurane, which would4 Advances in Pharmacological Sciences
lessen the inhibition of the parasympathetic output from the
vagal nerve, resulting in less tachycardia [43, 50]. Other an-
aesthetics do not induce tachycardia. The synthetic opiate
fentanyl produces bradycardia partly via inhibition of the
GABAergic pathways to the cardiac vagal neurons in the nu-
cleus ambiguus [51].
With respect to cardiovascular safety pharmacology,
knowledge about the profound eﬀect of anaesthetics on the
heartandvasculatureisimportantwhendesigningandinter-
preting studies of novel compounds and their possible det-
rimental eﬀects on the cardiovascular system. Considering
that GABA is the main inhibitory neurotransmitter in the
centralnervoussystemandtheimportanceoftheGABAergic
system in determining the ﬁring activity of the vagal cardiac
neurons, it is maybe of no surprise that drugs modulating
GABAA receptor activity will inﬂuence cardiac parameters.
However, the outcome of such modulations can be hard to
interpret and predict due to the complexity of these inte-
grative systems and reﬂexes.
4.Cardiovascular Effects of Positive Allosteric
Modulators of GABAA Receptors
BenzodiazepinesarepositiveallostericmodulatorsofGABAA
receptors.Thecardiovasculareﬀectsofbenzodiazepines have
been investigated in both animals and humans. Animal
studies have found that benzodiazepines result in lowered
blood pressure and variable eﬀects on heart rate. Findings
of reduced heart rates in anaesthetized animals were ex-
plained by reduction of sympathetic outﬂow [52, 53]. In
anaesthetised rats two benzodiazepine tested produced ta-
chycardia, and this eﬀect was attenuated by pretreatment
with atropine [54], suggesting an important role of the
parasympathetic nervous system. This role is also stressed
by a study demonstrating that application of the benzodi-
azepine, ﬂunitrazepam, increased the GABAergic input to
the cardiac vagal neurons, which lowered their excitability
and consequently reduced the parasympathetic outﬂow to
the heart [30]. Diﬀerences in species, the anaesthetics, and
the depth of anaesthesia used might help to explain these
varying eﬀects on heart rate. Because of the profound ef-
fects of general anaesthetics on cardiac regulation, the ef-
fectsofpositi v eallost ericmodulat orsofGAB A A receptors on
conscious animals are important. In conscious trained dogs
low doses of diazepam and bromazepam (p.o.) had no inﬂu-
ence on heart rate, but a rapid onset positive chronotropic
eﬀect was observed at higher doses (10mg/kg p.o.). The
onset was rapid and could not be reverted by the beta-
adrenoceptor blocking agents, indicating that the rapid heart
rate was not solely a result of increased sympathetic outﬂow
to the heart [55]. Using radiotelemetry devices diazepam
(6mg/kg i.p.) was found to increase the heart rate in
conscious rats [56]. Using a similar setup another GABAA
receptor potentiator JM-1232 was also found to increase
heartrate,andthiseﬀectwaspreventedbypretreatmentwith
atropine or propranolol. This indicates an involvement of
bothbranchesoftheautonomicnervoussystem.Theauthors
suggestthatthetachycardiacouldthereforebeaconsequence
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Figure 2: Eﬀect of diazepam on heart rate in artiﬁcially ventilated
(1%isoﬂurane,ﬁlledcircles;2.5%isoﬂurane,opencircles;O2 :N 2O
1:1) female guinea pigs (538 ± 27g). The animals were placed on
heated mats and the temperature was monitored and kept constant
at 37 ± 1◦C throughout the experiment. Electrocardiographic
(ECG) recordings were obtained using 2 electrodes placed in the
subcutaneous layer of the forelimbs (left and right), and 1 electrode
placed in the subcutaneous layer of the left hind limb. ECG
recordings were analysed using Chart ADinstrument software and
Graphpad Prism 5. A stabilization period of minimum 20min was
performed, followed by NaCl 0.9% i.p. Subsequently the animals
were injected intraperitoneally every 25th min with increasing
concentrations of diazepam (1, 3 and 10mg/kg i.p.).
of GABAergic inhibition of the vagal nerve output and/or
baroreﬂex activation due to hypotension [57].
In general the cardiovascular eﬀects of benzodiazepines
in humans, at clinically relevant doses, are mild [58]. How-
ever, during i.v. infusion, or with overdose, benzodiazepines
may cause hypotension and respiratory depression [59, 60].
Short acting, fast on-set benzodiazepines such as midazolam
are often used as premedication before surgical interven-
tions. When midazolam is injected i.v. it produces a rapid
drop in blood pressure and an increase in heart rate [59],
comparable to what is seen in conscious animals. A study
conducted to evaluate the inﬂuence of benzodiazepines on
the autonomic neurocardiac regulation in humans found a
similar rapid increase in resting heart rate and a concomitant
reduction in vagal tone, assessed by changes in heart rate
variability. A role for a baroreﬂex-induced tachycardia was
ruledoutasnosigniﬁcantfallinbloodpressurewasrecorded
[61].
Because the cardiac action potential in guinea pigs re-
sembles more closely the human cardiac action potential as
compared to other rodents, especially with respect to the re-
polarizing currents,guineapigsareapreferredanimalmodel
for initial screening for cardiovascular safety liabilities [62].
In guinea pigs artiﬁcially ventilated with isoﬂurane (1% or
2.5%, O2 :N 2O 1:1) administration of diazepam (1, 3 &
10mg/kg i.p.) produced no signiﬁcant changes in heart rate
as compared to saline injection (Figure 2). No signiﬁcantAdvances in Pharmacological Sciences 5
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Figure 3: Eﬀect of GABA 100μM (left column) or picrotoxin 100μM (right column) on isolated retrograde perfused female guinea pig
hearts. Hearts were excised, mounted in a Langendorﬀ apparatus, instrumented, and perfused with krebs-henseleit solution at a constant
pressure of 60mmHg as previously described [29]. Hearts were left to stabilize for a minimum of 30min. After 20min baseline recordings,
where ﬂow and heart rate was monitored, the hearts were paced from the right atrium for 2min at 240 BPM. This protocol was repeated in
the presence of GABA 100μMo rp i c r o t o x i n1 0 0μM( n = 5; GABA: 677±99g; Picrotoxin: 672±100g). GABA 100μMo rp i c r o t o x i n1 0 0μM
produced no signiﬁcant eﬀect on action potential duration (a), ﬂow (b), and heart rate (c).
changes in heart rate corrected QT-interval, PR-interval, or
temperature were observed (data not shown).
The lack of eﬀect of diazepam in the guinea pig on
heart rate as compared to rat could be a species- or dosage-
dependent phenomenon, but it could also stem from the use
and depth of anaesthesia which might already augment the
GABAergic input to the cardiac vagal neurons to such an
extent that further potentiation of GABAA receptors would
not cause any vagolytic eﬀect. In order to circumvent this we
will establish an in vivo setup using radiotelemetry implants
i no r d e rt oi n v e s t i g a t et h ein vivo eﬀects of positive allosteric
modulators of GABAA receptors in conscious guinea pigs.
This will also allow for simultaneous recordings of ECG,
blood pressure, temperature, and locomotor activity. Such6 Advances in Pharmacological Sciences
experimental condition will optimize the amount of data
that can be extracted from a single experiment and aid in
interpretation of drug-induced cardiovascular eﬀects.
5. Effect of GABA on the Isolated Heart
In addition to the central mediated GABAA receptor eﬀects
on the heart, studies have also suggested the presence of
GABAA receptors in the heart. One study found mRNA
expression encoding the GABAA receptor ε subunit in the
human cardiac conduction study [63] and in mouse GABAA
receptor protein was detected in the heart [64]. GABA
has been found in the guinea pig heart using [3H]-GABA,
especially in the area of the SA node and in the intrinsic
cardiac ganglion [8, 65]. It appears that there is no direct
GABAergic pathway connecting the nervous system to the
heart.Yet,GABAmightexertitseﬀectontheintrinsiccardiac
neurons, where it appears to play indirect modulatory eﬀects
[8, 66, 67]. The physiological role of GABAergic currents
in the intrinsic cardiac ganglion and their impact on heart
rate control need further investigation. However, in rat
GABA-evoked currents have been measured from intrinsic
cardiacneurons,butthecurrentamplitudedeclinedwithage
suggesting a role of GABAA receptors in the development of
the rat heart [65]. The intrinsic cardiac neurons, or intrinsic
cardiac ganglion, consist of both parasympathetic cholin-
ergic and sympathetic adrenergic postganglionic neurons
that receive input from the parasympathetic preganglionic
neurons in the brainstem and the preganglionic sympathetic
neurons found in the spinal cord. From here these neurons
project to the sinoatrial node. This classical view of the au-
tonomic ganglion functioning only as a passive relay station
from the central nervous system to the pacemaker cells of
the heart is too simple, because both interneurons and af-
ferent neurons are also found in the intracardiac ganglion.
This allows sensory information about the chemical and
mechanical state of the heart to be signalled to other neurons
within the intrinsic cardiac ganglion. This integration of
signals from both cardiac and extracardiac aﬀerents and how
they interact with the cardiac adrenergic and cholinergic
motorneurons are important for regulating cardiac function
(for review see [16]).
The isolated perfused heart is often used for cardio-
vascular safety pharmacology. The importance of GABAA
receptors in this preparation has been investigated. In rats,
adding GABA to the perfusion solution resulted in a dose-
dependent reduction in heart rate [68]. We did not observe
bradycardia in the isolated perfused guinea pig heart at a
GABA concentration, which was found to aﬀect the heart
rate in rat, nor was there any signiﬁcant eﬀect of GABA on
actionpotentialdurationorcoronaryﬂow.Likewiseblocking
GABAA receptors by administration of picrotoxin did not
produce any signiﬁcant eﬀects (Figure 3).
In order to obtain a more thorough overview of possible
GABAergic eﬀects on isolated heart we also tested the eﬀect
of positive allosteric modulation. In contrast to agonist
application in the form of GABA, we found that diazepam
produced a concentration-dependent reduction in heart
rate (Figure 4). This eﬀect on heart rate was however not
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Figure 4: Eﬀect of diazepam on isolated retrograde perfused
female guinea pig hearts (868 ± 45g). After a minimum of 30min
stabilization, the hearts underwent 20min of baseline recording.
Subsequently the hearts were exposed to diazepam at increasing
concentrations in 20min intervals. Diazepam induced a dose-
dependent reduction of heart rate and signiﬁcantly shortened the
heart rate at 30μM( n = 5).
prevented by coadministration of picrotoxin (Figure 5(a)),
suggesting that GABAA receptors are not involved in the
bradycardiac eﬀect. Another study found that diazepam
produced a negative inotropic response in isolated perfused
guineapigheartsthatwasnotpreventedbycotreatmentwith
GABAA or GABAB receptor antagonists [69]. Further, diaze-
pam application had no eﬀe c to na c t i o np o t e n t i a ld u r a t i o n
(APD) addressed by APD90 values or on coronary ﬂow
(Figures 5(b) and 5(c)). Diazepam has been found to inhibit
the cardiac calcium channel recorded from isolated guinea
pig cardiomyocytes [69], and to inhibit recombinant L-
type voltage-gated calcium channels [70]. The reduced cal-
cium inﬂux can explain the observed GABAA receptor-inde-
pendent eﬀects of diazepam on heart rate and contractil-
ity. However, it should be noted that the concentrations
needed to produce calcium channel block, and the brady-
cardia and negative inotropy observed in the isolated guinea
pig hearts are many folds above the therapeutic free plasma
concentration (∼0.2μM) and would so only be encountered
during overdose.
6. Conclusion
ThispaperfocusedontheeﬀectofGABAonthecardiacvagal
neurons and on the isolated heart. It is important to recog-
nize that regulation of heart rate not only involves these
parts, but is part of a complex integrated system involving
neurons located from the level of the insular cortex to the
level of the heart [16]. Because GABA is the main inhibitory
neurotransmitter in the central nervous system, the cardiac
eﬀects of modulating GABAA receptor activity, especially
with respect to GABAA receptor subtype selective com-
pounds, are hard to predict and require careful investigation.Advances in Pharmacological Sciences 7
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Figure 5: The eﬀect of diazepam (10μM), diazepam (10μM) + picrotoxin (100μM) (co-administration), and picrotoxin (100μM) on heart
rate (a), action potential duration (b), and coronary ﬂow (c). Hearts were left to stabilize for a minimum of 30min. 20min of baseline
recordings were performed, where heart rate and ﬂow were monitored. The hearts were then paced from the right atrium at 240 BPM for
2min in order to measure the action potential duration at a ﬁxed heart rate. This (20+2) protocol was repeated for the diﬀerent drugs
investigated (n = 5; ∗P ≤ 0.05 (1-way ANOVA); (715 ±129g)).
Inthisrespectitwillbeinterestingtoobtainmoreknowledge
about the GABAA receptor subunit composition in the neu-
ronal pathways involved in heart rate control. Considering
the profound eﬀects of anaesthetics on the GABAergic sys-
t e m ,a n do nn e u r o n a lp a t h w a y si n v o l v e di nh e a r tr a t ec o n -
trol, it argues for the use of conscious freely moving animals
at early stages during cardiovascular safety pharmacology
proﬁling of novel compounds targeting the GABAA recep-
tor. Such cardiovascular safety pharmacology investigations
could well be combined with behavioural assessment [71].
This will aid in interpretation of drug-induced eﬀects and
increase the amount of data generated per animal, thereby
reducing the number of animals used.
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